Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Apr 2 2025 | Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo Industry News In The News Industry Read More Apr 2 2025 | Welcoming March's New HFSA Members HFSA News Membership Read More Apr 1 2025 | Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM Industry News In The News Industry Read More Mar 27 2025 | BridgeBio to Present Cardiovascular Outcomes Data in Patients with Variant and Wild-type Transthyretin Amyloid Cardiomyopathy (ATTR-CM) from the ATTRibute-CM Study at the ACC Annual Scientific Sessions Industry News In The News Industry Read More Mar 27 2025 | Highnoon Labs’ Commits to Advancing Heart Failure Care Through HFSA’s OMT-HF Certificate Program HFSA News Provider Education Read More Pagination First page « First Previous page ‹ Previous … Page 18 Page 19 Page 20 Page 21 Current page 22 Page 23 Page 24 Page 25 Page 26 … Next page Next › Last page Last »
Apr 2 2025 | Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo Industry News In The News Industry Read More
Apr 1 2025 | Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM Industry News In The News Industry Read More
Mar 27 2025 | BridgeBio to Present Cardiovascular Outcomes Data in Patients with Variant and Wild-type Transthyretin Amyloid Cardiomyopathy (ATTR-CM) from the ATTRibute-CM Study at the ACC Annual Scientific Sessions Industry News In The News Industry Read More
Mar 27 2025 | Highnoon Labs’ Commits to Advancing Heart Failure Care Through HFSA’s OMT-HF Certificate Program HFSA News Provider Education Read More
